Edgewood Oncology
Brookline, MA
Edgewood Oncology is a clinical-stage biotechnology business established to fulfill the potential of BTX-A51 for patients with solid tumors that are genetically specified and hematologic malignancies. Our goal is to create a novel treatment that will prolong and enhance the lives of those with the greatest unmet medical needs.
edgewoodoncology.comCompany Details
Founded
- 2023
Employees
- Between 2 - 10 employees
Raised
- $20,000,000
Headquarters Location
- Brookline, MA
Public
- No
Acquired
- No
CEO
David Cook
Founders
- David Cook
Company Collections
These are collections Edgewood Oncology is a part of. Click on the collection name to view similar companies.